Official ESCRS | European Society of Cataract & Refractive Surgeons
Copenhagen 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Glaucoma Day 2016 Hotel Star Alliance

10 - 14 Sept. 2016, Bella Center, Copenhagen, Denmark

This Meeting has been awarded 27 CME credits


escrs app advert yo advert

Safety and efficacy of implantation of the FEMTIS Laser Lens using the LENSAR™ laser system: a series of 76 eyes

Search Title by author or title

Session Details

Session Title: Pseudophakic IOLs: Monofocal/Accommodative

Session Date/Time: Tuesday 13/09/2016 | 16:30-18:00

Paper Time: 17:12

Venue: Hall C2

First Author: : D.Holland GERMANY

Co Author(s): :    M. Poelzl                    

Abstract Details


Femtosecond Laser Assisted Cataract surgery is gaining wide acceptance due to its potential of better safety, predictability and efficacy. Proper centration and positioning of the IOLs is fundamental to achieving improved outcomes possible with premium IOLs. Due to the highly predictable size and position of capsulotomy possible with femtosecond laser, laser assisted capsulotomy can potentially serve as an avenue to improve the centration of the IOL. FEMTIS Laser Lens (Oculentis) has a special haptic system, which allows the lens to clamp into capsulorhexis. This study evaluates up to 24 months outcomes of FEMTIS laser lens implantation in 90 eyes.


nordBLICK Augenklinik Bellevue Eye Hospital, Kiel, Germany


Study included 90 eyes (66 patients) with cataract that underwent femtosecond laser assisted cataract surgery (FLACS). (Mean age 75±8years.) Surgeries were performed by a single surgeon. Femtosecond laser assisted capsulotomy, lens fragmentation, clear corneal cataract incisions were performed using the LENSAR™ femtosecond Laser System. Capsulorhexis was prepared with a diameter of 4.8 mm and was centered at the pupil center. Phacoemulsification was performed with the OS3 phaco system (Oertli, Switzerland). After implantation of the FEMTIS laser lens, ophthalmic viscoelastic device was carefully removed from behind the lens. Afterwards, additional haptics were used to clamp the IOL into the capsulorhexis.


No intraoperative lens design related complications happened; particularly no tears of the capsulotomy. The lens was centered on the rhexis in all cases even in the follow up. Average lens power was 20.0dpt. Post-operatively, there were no lens-related complications, e.g. no iris capture. The refractive and visual outcomes were comparable to our standard IOL in cataract surgery. The SEQ postoperatively preoperatively was 0.34 (range -5.5dpt to 3.62dpt) and postoperatively +0.26 (range -0.38dpt to 0.88) .DCVA improved from 0.5 to 0.9 postoperatively. IOP was within the norm.


The implantation of FEMTIS laser lens was found to be safe and effective during the study follow-up of up to 2 years. The centering of the lens was maintained on the capsulotomy and was independent of influences of the capsular bag through the duration of the study. Refractive outcome was stable over the time. Continued follow-up over longer duration is needed to determine the long-term safety and efficacy of the new IOL. The new IOL design has furthermore the potential for development of new additive IOL which use the haptics in front of the capsulotomy for support.

Financial Disclosure:

... receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented

Back to previous